Form 4: Schwab Director Carolyn Schwab-Pomerantz Executes Stock Option and Sells Shares

Sentiment:

SEC Form 4 Filing


Director Carolyn Schwab-Pomerantz exercised stock options and sold shares of Schwab (SCHW) on April 18th and 19th, 2024, according to a Form 4 filing with the SEC.

Summary

  • Carolyn Schwab-Pomerantz, a director of Schwab, executed a nonqualified stock option on April 18, 2024, acquiring 7,482 shares of common stock at a price of $28.44 per share.
  • On the same day, she contributed these 7,482 shares to a revocable trust.
  • Also on April 18, 2024, she sold 7,482 shares at a weighted average price of $73.4653, with individual transactions ranging from $73.2701 to $73.585.
  • On April 19, 2024, she sold an additional 5,400 shares at a weighted average price of $73.1671 (ranging from $72.88 to $73.42) and 3,600 shares at a weighted average price of $73.1572 (ranging from $72.88 to $73.41) pursuant to a 10b5-1 trading plan.
  • Following these transactions, Schwab-Pomerantz directly owns 6,353 shares and indirectly owns 1,713,998.6599 shares through a trust, 577,857 shares through her spouse as trustee, and 2,798 shares through an LLC.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports transactions. The existence of a 10b5-1 plan suggests pre-planned sales, reducing the impact of the sales.

Industry Context

Insider transactions are routinely monitored by investors as they can provide insights into a company's prospects, although they don't always indicate a definitive trend. In this case, the transactions are partially governed by a pre-arranged trading plan.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the potential dilution from option exercises and the selling pressure from the share sales.
  • However, the existence of a pre-arranged trading plan mitigates concerns about opportunistic trading.

Key Dates

DateDescription
11/03/2015Option vesting start date
11/10/2023Adoption date of Rule 10b5-1 trading plan
04/18/2024Date of option exercise and initial share sales
04/19/2024Date of subsequent share sales
11/03/2024Option expiration date
04/22/2024Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.